Annals of Family Medicine

NOVEMBER 20, 2024

Context: The human papillomavirus (HPV) vaccine is recommended starting at age 9 to reduce risk of HPV linked squamous cell cancers, yet recent data shows that only 58.6% have been vaccinated by age 17. Secondary acceptance is agreeing to a vaccine subsequent to declining in a previous encounter. Child (e.g.,

Vaccination 130

Vaccination Family Medicine DO Primary Care 130

Physician's Weekly

JUNE 19, 2025

Data came from the three influenza seasons from 2012 to 2015. Most patients (71.0%) had received the current season’s RSV vaccine. Melissa Andrew, MD, PhD , and colleagues assessed data from a severe outcomes surveillance network housed within a larger immunization research network. Additionally, 63.8% of the patients were women.

Illness 52

Illness Hospital Patients Management 52

FDA Law Blog

JUNE 7, 2021

However, the FDA guidance goes on to say in some cases, additional context is needed by specifically inserting a sentence in the indications statement that: no clinical benefit has been established. be “reasonably likely to predict” ultimate clinical benefit).

Clinic 98

Clinic IT Private Practice Utilities 98